Pfizer, Sanofi, Takeda Pharmaceutical, and other drugmakers will raise the prices of more than 500 drugs in early January, according to an analysis by health care researchers 3 Axis Advisors. Inflation and rising manufacturing costs will contribute to the price increases… as well as, ironically, a government initiative to lower drug costs.

Reuters reports that manufacturers are hiking their prices partially in preparation of last fall’s agreement with the Biden Administration to significantly drop prices on certain high-cost medications… the first such price negotiation in a program created under the Inflation Reduction Act.

If you’re looking for some proven solutions to counter rising drug costs, MedBen Rx has them. They include:

  • Pricing Solutions that ensure you pay the lowest pharmacy pricing available to your organization;
  • Access Solutions, including benefit preservation programs to deliver best-in-marketing pricing for specialty drugs; and
  • Appropriateness Solutions that use clinical-based research to find the most effective drugs for your plan members.

Learn how MedBen Rx pharmacy solutions lead to lower costs and better outcomes by contacting your broker or calling our Marketing Department at 888-627-8683.